Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
2.740
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
2.580
-0.160 (-5.84%)
After-hours: Dec 5, 2025, 6:54 PM EST
Treace Medical Concepts Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 175 | 463 | 786 | 1,276 | 991 | - | |
| Market Cap Growth | -63.89% | -41.06% | -38.37% | 28.74% | - | - | |
| Enterprise Value | 188 | 451 | 735 | 1,259 | 911 | - | |
| Last Close Price | 2.74 | 7.44 | 12.75 | 22.99 | 18.64 | - | |
| PS Ratio | 0.79 | 2.21 | 4.20 | 9.00 | 10.50 | - | |
| PB Ratio | 1.96 | 4.11 | 5.70 | 21.08 | 10.65 | - | |
| P/TBV Ratio | 2.53 | 5.04 | 6.77 | 21.08 | 10.65 | - | |
| EV/Sales Ratio | 0.86 | 2.15 | 3.93 | 8.88 | 9.65 | - | |
| Debt / Equity Ratio | 0.79 | 0.62 | 0.51 | 1.13 | 0.32 | 40.24 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 15.12 | |
| Asset Turnover | 1.07 | 0.89 | 0.91 | 0.95 | 1.03 | 1.60 | |
| Inventory Turnover | 1.04 | 1.20 | 1.45 | 1.71 | 1.84 | 1.86 | |
| Quick Ratio | 2.22 | 3.35 | 3.61 | 3.67 | 6.83 | 2.81 | |
| Current Ratio | 3.37 | 4.62 | 4.41 | 4.41 | 7.58 | 3.53 | |
| Return on Equity (ROE) | -51.63% | -44.45% | -49.91% | -55.75% | -43.80% | -186.34% | |
| Return on Assets (ROA) | -14.77% | -14.83% | -15.64% | -14.53% | -11.30% | 1.49% | |
| Return on Capital (ROIC) | -18.08% | -17.80% | -19.05% | -17.30% | -13.35% | 1.97% | |
| Return on Capital Employed (ROCE) | -31.10% | -30.50% | -24.90% | -27.10% | -13.50% | 2.80% | |
| Earnings Yield | -28.70% | -12.03% | -6.30% | -3.36% | -2.07% | - | |
| FCF Yield | -15.09% | -10.52% | -5.85% | -3.56% | -2.01% | - | |
| Buyback Yield / Dilution | -1.51% | -2.07% | -10.09% | -14.17% | -30.61% | -0.43% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.